Target intelligence / Profile preview

Ocular surface tear film and epithelial cell membranes

Molecular classification
Other
01

Overview

The ocular surface tear film and epithelial cell membranes form a dynamic functional unit essential for ocular homeostasis, providing a smooth optical surface and protecting the eye from environmental damage (StatPearls, 2023). The tear film is a complex mixture of lipids, water, and mucins that lubricates the eye and delivers nutrients to the avascular cornea (NIH, 2022). The underlying epithelial cell membranes, particularly the corneal and conjunctival epithelium, are covered by a glycocalyx of membrane-associated mucins like MUC1 and MUC16, which facilitate tear film stability and act as a barrier against pathogens (PubMed, 2021). Dysfunction of this system is the hallmark of Dry Eye Disease (DED), where tear film instability and hyperosmolarity lead to inflammation and damage to the ocular surface (TFOS DEWS II, 2017). Pharmacological treatments include lubricants to supplement the tear film, secretagogues to increase production, and anti-inflammatory agents like cyclosporine or lifitegrast to address the underlying immune response (FDA, 2023).

Other names
Precorneal tear filmOcular surface unitTear film-ocular surface interfaceCorneal glycocalyx
02

Mechanism of action

Drugs targeting this system work through various mechanisms including: lubrication and hydration of the ocular surface; stabilization of the tear film lipid layer to prevent evaporation; inhibition of T-cell mediated inflammation and cytokine release; antagonism of lymphocyte function-associated antigen-1 (LFA-1); and stimulation of the trigeminal parasympathetic pathway to increase natural tear production (StatPearls, 2023; FDA, 2023).

03

Biological functions

LubricationRefractionImmune defenseBarrier functionNutrient transportOsmotic regulation
04

Disease associations

Dry eye diseaseKeratoconjunctivitis siccaSjögren's syndromeCorneal ulcerKeratitisMeibomian gland dysfunction
05

Safety considerations

Transient blurred visionOcular stinging or burningRisk of secondary ocular infectionHypersensitivity reactionsDysgeusia (with certain nasal sprays or drops)
06

Interacting drugs

Cyclosporine

9 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)Tear osmolaritySchirmer's test scoreCorneal fluorescein stainingMatrix metalloproteinase-9 (MMP-9) levels

Beyond the preview

Go deeper on Ocular surface tear film and epithelial cell membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface tear film and epithelial cell membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call